According to a recently filed product liability lawsuit, exposure to valsartan drugs containing impurities caused a Mississippi man colon cancer.
The lawsuit was filed by a plaintiff in the U.S. District Court for the Southern District of Mississippi against Aurobindo Pharma and Acetris, LLC. The plaintiff stated that he was prescribed valsartan for the treatment of high blood pressure in February 2017. He was diagnosed with colon cancer, and in February 2018, he discovered that the pills he consumed were recalled due to contamination reports. The lawsuit stated that the manufacturers purposely concealed that the drug contained carcinogens, such as N-nitrosodimethylamine (NDMA) or N-Nitrosodiethylamine (NDEA), until the FDA issued its recall in July 2018. These chemicals have been reported to cause liver cancer, colon cancer, stomach cancer, and other digestive tract cancers.
This case is one among the growing number of valsartan recall lawsuits filed in recent months by individuals who were affected by the drug contamination.
